CSNK1A1 and Miyoshi myopathy: Therefore, targeting CK1α in PCs could be beneficial not only in terms of killing MM cells, as observed in [23,37], but also in terms of downregulating the detrimental effects of MM-restricted RUNX2 protein expression.